Myron Z. Holubiak - Aug 14, 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Vice Chairman, Director
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Aug 14, 2024
Transactions value $
$0
Form type
4
Date filed
9/27/2024, 05:27 PM
Previous filing
Aug 14, 2024
Next filing
Nov 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 1.99M Aug 14, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Warrant to Purchase Common Stock Disposed to Issuer -784K -100% 0 Aug 14, 2024 Common Stock 784K $1.15 Direct F1
transaction CTXR Warrant to Purchase Common Stock Award +784K 784K Aug 14, 2024 Common Stock 784K $1.15 Direct F1
transaction CTXR Warrant to Purchase Common Stock Disposed to Issuer -559K -100% 0 Sep 25, 2024 Common Stock 559K $0.77 Direct F2
transaction CTXR Warrant to Purchase Common Stock Award +559K 559K Sep 25, 2024 Common Stock 559K $0.77 Direct F2
holding CTXR Warrant to Purchase Common Stock 129K Aug 14, 2024 Common Stock 129K $1.42 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 400K Aug 14, 2024 Common Stock 400K $0.70 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 400K Aug 14, 2024 Common Stock 400K $1.25 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 650K Aug 14, 2024 Common Stock 650K $2.04 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 15K Aug 14, 2024 Common Stock 15K $2.04 See footnote F7
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Aug 14, 2024 Common Stock 300K $2.00 Direct F8
holding CTXR Stock Option (Right to Purchase Common Stock) 10K Aug 14, 2024 Common Stock 10K $2.00 See footnote F7
holding CTXR Stock Option (Right to Purchase Common Stock) 200K Aug 14, 2024 Common Stock 200K $1.01 Direct F9
holding CTXR Stock Option (Right to Purchase Common Stock) 175K Aug 14, 2024 Common Stock 175K $0.67 Direct F9
holding CTXR Stock Option (Right to Purchase Common Stock) 150K Aug 14, 2024 Common Stock 150K $1.62 Direct F9
holding CTXR Stock Option (Right to Purchase Common Stock) 40K Aug 14, 2024 Common Stock 40K $3.45 Direct F9
holding CTXR Stock Option (Right to Purchase Common Stock) 26.7K Aug 14, 2024 Common Stock 26.7K $8.10 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.
F2 The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.
F3 The warrant is fully vested and exercisable immediately.
F4 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F5 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F6 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F7 The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
F8 The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F9 The options are vested in full and exercisable immediately.